Summary:
The objective of this study is to determine the efficacy, safety and tolerability of the SM04690 Injectable Suspension 0.07mg dose in the treatment of knee osteoarthritis (OA).
Qualified Participants Must:
• Be between 40-80 years of age
•
Have had arthritis in the knee for at least 1 year prior
•
Not currently taking any pain medications
•
Have not had either knee or hip replaced
Qualified Participants May Receive:
- Compensation for time and travel expenses
- Study related procedures such as blood work and ECG
- Physcial performed by a board certified physician